Tirzepatide Prescribing at MYRTLE GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
363
Total Quantity
399
NHS Cost
£38.2K
vs National Avg
+86.9%
MYRTLE GROUP PRACTICE prescribed 363 items of Tirzepatide over the last 12 months at a cost of £38,198 to the NHS. This is 86.9% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
1
Jun 2026
7
Jun 2026
7
Jun 2026
20
Jun 2026
28
Jun 2026
36
Jun 2026
31
Jun 2026
40
Jun 2026
38
Jun 2026
53
Jun 2026
50
Jun 2026
52
Prescribing Details
| Total Items | 363 |
|---|---|
| Total Quantity | 399 |
| Total NHS Cost | £38,198 |
| Presentations | 11 different forms |
| vs National Average | +86.9% |
Tirzepatide Prescribing Comparison
| This practice | 363 items |
|---|---|
| National average per practice | 194 items |
| Difference | +86.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.